Patents by Inventor Mohsen Arghavani

Mohsen Arghavani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210139489
    Abstract: Provided herein are methods of treating painful diabetic peripheral neuropathy, such as advanced painful DPN, in a patient by administering to the patient an effective amount of NYX-2925 or a pharmaceutically acceptable salt thereof. Also provided are crystalline forms of 3-hydroxy-2-(5-isobutyryl-1-oxo-2,5-diazaspiro[3,4]octan-2-yl)butanamide.
    Type: Application
    Filed: November 10, 2020
    Publication date: May 13, 2021
    Inventors: Torsten M. Madsen, M. Amin Khan, Mohsen Arghavani, Phil Bauer, Eduardo Mar
  • Publication number: 20200254050
    Abstract: The disclosure relates to intravenous formulations of GLYX peptides for treating CNS Disorders such as depression, neuropathic pain, or anxiety.
    Type: Application
    Filed: January 23, 2020
    Publication date: August 13, 2020
    Inventors: DAVID HOUCK, MOHSEN ARGHAVANI
  • Publication number: 20170049844
    Abstract: The disclosure relates to intravenous formulations of GLYX peptides for treating CNS Disorders such as depression, neuropathic pain, or anxiety.
    Type: Application
    Filed: April 27, 2015
    Publication date: February 23, 2017
    Applicant: Naurex Inc.
    Inventors: DAVID HOUCK, MOHSEN ARGHAVANI
  • Publication number: 20050137517
    Abstract: Systems and methods process blood and blood components for subsequent pathogen inactivation processes prior to long term storage and/or transfusion.
    Type: Application
    Filed: December 19, 2003
    Publication date: June 23, 2005
    Inventors: Bryan Blickhan, Mary Stewart-Wesson, Daniel Bischof, Mohsen Arghavani, Lawrence Servi, Daniel Lynn, Tat Mui, Michael Mayo